Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

The global insulin pens market size was valued at USD 7.46 billion in 2024 and is projected to reach from USD 8.05 billion in ...

Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

A survey by MSF and T1 International highlighted that insulin injected from pen devices is preferred by 82% of people with diabetes over insulin in vials injected with syringes, due to its accuracy, ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

The international medical charity Doctors Without Borders has called on leading pharmaceutical corporations and "all insulin ...

The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.

When Wright's mealtime insulin was down to a partial vial in January ... a dozen insulin products and more than 800 million insulin pens a year. "Not only are we not winding down our work for ...

When Wright's mealtime insulin was down to a partial vial in January, she ate fewer carbohydrates to ... more than a dozen ...